Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration

HB 4721 would amend West Virginia's drug scheduling law to automatically remove a specific form of psilocybin - crystalline polymorph psilocybin - from Schedule I if approved by the FDA and DEA for medical use. This change would apply only to the crystalline form of psilocybin that receives federal approval, not to other forms or uses of psilocybin. The bill creates a direct pathway for this specific approved form to be legally accessible for medical purposes without requiring additional state legislation. It does not change current restrictions on other psilocybin forms or recreational use.